by Valet | Apr 2, 2021 | Blog, Osteoarthritis, Stem Cell
Though there is still much to learn about the therapeutic effects of stem cell therapy, stem cell research has come a long way in the past few decades. Through a multitude of studies for a variety of conditions, researchers have made many important discoveries...
by Valet | Mar 30, 2021 | Clinical Trial, FDA Approved Clinical Trial, Press Release
Personalized Stem Cells, Inc (PSC), a clinical stage biopharma cell therapy company, announces the results of its single knee osteoarthritis phase 1/2a clinical trial. The final study report has been submitted to the FDA for review and in support of a full-scale...
by Valet | Mar 19, 2021 | Blog, COVID-19, Regenerative Medicine, Stem Cell
While there are several sources of mesenchymal stem cells (MSCs), two of the most common sources include adipose tissue and bone marrow. At Personalized Stem Cells, we process adipose (fat) tissue to extract and concentrate MSCs for use in FDA-approved clinical...
by Valet | Mar 5, 2021 | Blog, Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis. It is a degenerative disease in which the cartilage within a joint breaks down, causing changes in the surrounding bone. Common symptoms of OA include pain, stiffness, and reduced range of motion. While any...
by Valet | Feb 19, 2021 | Blog, Clinical Trial, COVID-19, FDA Approved Clinical Trial
In 2020, Personalized Stem Cells developed and secured FDA approval for a COVID-19 stem cell clinical trial. In October of last year, we announced that we out-licensed our allogeneic stem cell program, including the COVID-19 therapy, to Sorrento Therapeutics....